Several Drug-Related Bills Likely to Die with 112th Congress
As the House and Senate limp toward their lame duck session with a slate full of tax cut, budget and sequestration issues, it's likely that a number of drug-related bills still sitting in committee will die with the 112th Congress.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST